Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
01/04/2001 | WO2001000622A1 Prodrugs of carbamate inhibitors of impdh |
01/04/2001 | WO2001000618A1 Benzamide derivatives |
01/04/2001 | WO2001000587A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
01/04/2001 | WO2001000585A1 Pyrazolidinol compounds |
01/04/2001 | WO2001000244A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
01/04/2001 | WO2001000230A1 Drug composition containing lecithin-modified superoxide dismutase |
01/04/2001 | WO2001000217A1 Medicinal compositions for preventing or treating diarrhea |
01/04/2001 | WO2001000214A1 Src kinase inhibitor compounds |
01/04/2001 | WO2001000213A1 Src kinase inhibitor compounds |
01/04/2001 | WO2001000210A1 Reverse-turn mimetics and methods relating thereto |
01/04/2001 | WO2001000209A1 Methods of use of fluoroquinolone compounds against bacteria |
01/04/2001 | WO2001000207A1 Src kinase inhibitor compounds |
01/04/2001 | WO2001000185A2 1,4-denzothiazepines to treat obesity related disorders |
01/04/2001 | WO2001000045A1 Drinks and foods capable of eliminating helicobacter pylori |
01/04/2001 | WO2000060082A3 Vesicle associated proteins |
01/04/2001 | WO2000044761A3 Ketolide antibiotics |
01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
01/04/2001 | CA2435411A1 Method of inducing angiogenesis by micro-organs |
01/04/2001 | CA2383546A1 Src kinase inhibitor compounds |
01/04/2001 | CA2378221A1 Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype |
01/04/2001 | CA2377721A1 Sgip peptides |
01/04/2001 | CA2377541A1 Method of inducing angiogenesis by micro-organs |
01/04/2001 | CA2377265A1 Somatostatin agonists |
01/04/2001 | CA2377200A1 Pyrazolidinol compounds |
01/04/2001 | CA2376957A1 Src kinase inhibitor compounds |
01/04/2001 | CA2376951A1 Src kinase inhibitor compounds |
01/04/2001 | CA2376938A1 Medicinal compositions for preventing or treating diarrhea |
01/04/2001 | CA2376023A1 Therapeutic agents |
01/04/2001 | CA2375952A1 Reverse-turn mimetics and methods relating thereto |
01/04/2001 | CA2365341A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
01/03/2001 | EP1065208A1 Substituted purine derivatives as inhibitors of cell adhesion |
01/03/2001 | EP1064950A1 Remedies for hepatitis |
01/03/2001 | EP1064941A1 Use of melatoninergic ligands for obtaining pharmaceutical compositions for the prevention or the treatment of gastrointestinal pathologies |
01/03/2001 | EP1064403A1 Antisense modulation of pecam-1 |
01/03/2001 | EP1064402A1 Antisense modulation of lfa-3 |
01/03/2001 | EP1064376A2 GFR$g(a)3 AND ITS USES |
01/03/2001 | EP1064277A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
01/03/2001 | EP1064262A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
01/03/2001 | EP1064256A1 Bicyclo [2.2.1] heptanes and related compounds |
01/03/2001 | EP1064006A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
01/03/2001 | EP1064001A2 Methods and compositions for treating and preventing mucositis |
01/03/2001 | EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors |
01/03/2001 | EP1063988A1 Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor ofmacrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases |
01/03/2001 | EP1063987A1 Dietary control of arachidonic acid metabolism |
01/03/2001 | EP1063984A1 Inflammatory cell inhibitors |
01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
01/03/2001 | CN1278821A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
01/03/2001 | CN1278820A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
01/03/2001 | CN1278816A 5,11-Dihydrodibenz [b,e] [1,4] oxazepine derivaties and medicinal composition containing the same |
01/03/2001 | CN1278815A 3-oxo-2(H)-1,2,4-triazine derivativs as ligands of 5HT1A receptors |
01/03/2001 | CN1278810A Substituted benzodihydropyran derivatives |
01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
01/03/2001 | CN1278800A Cyclohexane derivatives difunctionalised in 1.4 as ligands of 5T hia receptors |
01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
01/03/2001 | CN1278733A Viscous compositions containing carbon dioxide |
01/03/2001 | CN1278726A IL-8 receptor antagonists |
01/03/2001 | CN1278725A Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives |
01/03/2001 | CN1278724A Indeno [1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activty |
01/03/2001 | CN1278722A 8a-azalides as veterinary antimicrobial agents for animals |
01/03/2001 | CN1278721A IL-8 receptor antagonists |
01/03/2001 | CN1278530A Novel peptide derivative |
01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
01/03/2001 | CN1060087C Traditional Chinese medicine extract tablet and preparation method therefor |
01/03/2001 | CN1060086C Traditional Chinese medicine capsule for eliminating indurated goiter |
01/03/2001 | CN1060077C Chinese patent medicine for gastric disease and duodenal disease and its preparing method |
01/03/2001 | CN1060070C External application medicinal bag for curing acute and chronic cholecystitis and its producing method |
01/03/2001 | CN1060067C Drug for curing jaundice |
01/03/2001 | CN1060065C Medicine for chelicystitis |
01/03/2001 | CN1060052C Traditional Chinese powder medicine for dog diseases |
01/03/2001 | CN1060049C Chinese medicine ganshenxianbao for curing liver and kidney diseases and its preparing method |
01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
01/02/2001 | US6169083 Administering an l-carnosine zinc salt or l-carnosine-zinc complex; treating the side effect of cancer chemotherapy or radiotherapy |
01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
01/02/2001 | US6168920 Extracellular adhesive proteins |
01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
01/02/2001 | CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
01/02/2001 | CA2174034C Novel tricyclic amides, processes for their preparation and the pharmaceutical compositions which contain them |
01/02/2001 | CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues |
12/28/2000 | WO2000078980A1 Method for producing plants with increased flavonoid and phenolic compound content |
12/28/2000 | WO2000078972A2 Regulation with binding cassette transporter protein abc1 |
12/28/2000 | WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides |
12/28/2000 | WO2000078953A2 Human transport proteins |
12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
12/28/2000 | WO2000078768A1 Potassium channel openers |
12/28/2000 | WO2000078762A1 Indoloazepines as vasopressin receptor antagonists |
12/28/2000 | WO2000078759A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
12/28/2000 | WO2000078757A1 Inhibitors of il-12 production |
12/28/2000 | WO2000078745A2 Crystalline form of (r)-2-[[[3-methyl- 4- (2,2,2,- trifluoroethoxy) -2- pyridinyl] methyl] sulfinyl] -1h-benzimidazole |
12/28/2000 | WO2000078735A1 Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof |
12/28/2000 | WO2000078720A1 Novel dihydropyridine derivative |
12/28/2000 | WO2000078719A1 Dihydropyridine derivative |
12/28/2000 | WO2000078360A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
12/28/2000 | WO2000078346A1 Novel anti-allergic agents |
12/28/2000 | WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders |
12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |